DHR · Danaher Corp
United States · RS rating 85 · As of 2026-10-14
| Price | 224.69 USD |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 85 / 92 / 85 / 61 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 49 / 45 / 50 |
| Industry group (rank) | Medical-Diversified (32) |
| EPS growth Q/Q | +32.3% |
| Sales growth Q/Q | +13.0% |
| Distance from 52-week high | +7.2% |
| Market cap (USD) | $126.4B |